{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T07:57:23Z","timestamp":1648713443797},"reference-count":19,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.lpm.2009.04.016","type":"journal-article","created":{"date-parts":[[2010,9,4]],"date-time":"2010-09-04T07:04:51Z","timestamp":1283583891000},"page":"1066-1070","source":"Crossref","is-referenced-by-count":0,"title":["Pemphigus"],"prefix":"10.1016","volume":"39","author":[{"given":"H\u00e9l\u00e8ne","family":"Lapeyre-Li\u00e9nard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"Joly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2009.04.016_bib0005","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1067\/mjd.2000.107488","article-title":"Sensitivity and specificity of clinical, histologic, and immunologic features in the diagnosis of paraneoplastic pemphigus","volume":"43","author":"Joly","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.lpm.2009.04.016_bib0010","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1046\/j.1365-2133.2001.04132.x","article-title":"The severity of cutaneous and oral pemphigus is related to desmoglein 1\u00a0and 3\u00a0antibody levels","volume":"144","author":"Harman","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.lpm.2009.04.016_bib0015","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1001\/archdermatol.2009.9","article-title":"Elisa testing of antidesmoglein antibodies in the management of pemphigus","volume":"145","author":"Abasq","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.lpm.2009.04.016_bib0020","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00403-008-0901-y","article-title":"Detection of antienvoplakin and antiperiplakin autoantibodies by Elisa in patients with paraneoplastic pemphigus","volume":"301","author":"Huang","year":"2009","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.lpm.2009.04.016_bib0025","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.clim.2008.07.021","article-title":"Detection and characterization of antienvoplakin linker autoantibodies in paraneoplastic pemphigus using specific bead-based assay","volume":"129","author":"Mouquet","year":"2008","journal-title":"Clin Immunol"},{"key":"10.1016\/j.lpm.2009.04.016_bib0030","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.jaad.2008.01.012","article-title":"Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus","volume":"58","author":"Murrell","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.lpm.2009.04.016_bib0035","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1001\/archderm.1984.01650370050009","article-title":"Treatment of pemphigus vulgaris. Results obtained in 84\u00a0patients between 1961\u00a0and 1982","volume":"120","author":"Lever","year":"1984","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.lpm.2009.04.016_bib0040","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1001\/archderm.1987.01660300105021","article-title":"Dapsone as initial treatment in superficial pemphigus. Report of nine cases","volume":"123","author":"Basset","year":"1987","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.lpm.2009.04.016_bib0045","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/archderm.144.1.25","article-title":"Multicenter randomized, double-blind, placebo-controlled, clinical trial of dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgaris","volume":"144","author":"Werth","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.lpm.2009.04.016_bib0050","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jaad.2007.05.024","article-title":"Randomized-controlled open-label trial of four treatment regimens for pemphigus vulgaris","volume":"57","author":"Chams-Davatchi","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.lpm.2009.04.016_bib0055","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1002\/art.10947","article-title":"Rituximab therapy and autoimmune disorders: prospects for anti-B cell therapy","volume":"48","author":"Silverman","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.lpm.2009.04.016_bib0060","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJMoa067752","article-title":"A single cycle of rituximab for the treatment of severe pemphigus","volume":"357","author":"Joly","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2009.04.016_bib0065","doi-asserted-by":"crossref","first-page":"7359","DOI":"10.1038\/sj.onc.1206939","article-title":"Rituximab (monoclonal anti-CD20\u00a0antibody): mechanisms of action and resistance","volume":"22","author":"Smith","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.lpm.2009.04.016_bib0070","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1053\/sonc.2002.30156","article-title":"Rituximab: mechanism of action and resistance","volume":"29","author":"Maloney","year":"2002","journal-title":"Semin Oncol"},{"key":"10.1016\/j.lpm.2009.04.016_bib0075","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1056\/NEJMoa062930","article-title":"Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin","volume":"355","author":"Ahmed","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2009.04.016_bib0080","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/1096-8652(200102)66:2<142::AID-AJH1032>3.0.CO;2-0","article-title":"Successful treatment of paraneoplastic pemphigus in follicular NHL with rituximab: report of a case and review of treatment for paraneoplastic pemphigus in NHL and CLL","volume":"66","author":"Heizmann","year":"2001","journal-title":"Am J Hematol"},{"key":"10.1016\/j.lpm.2009.04.016_bib0085","first-page":"269","article-title":"Anti-CD20\u00a0monoclonal antibody (rituximab) for refractory erosive stomatitis secondary to CD20(+) follicular lymphoma-associated paraneoplastic pemphigus","volume":"137","author":"Borradori","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.lpm.2009.04.016_bib0090","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1056\/NEJMcpc030016","article-title":"Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 23-2003. A 79-year-old woman with gastric lymphoma and erosive mucosal and cutaneous lesions","volume":"349","author":"Ahmed","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2009.04.016_bib0095","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1001\/archdermatol.2008.503","article-title":"Effect of intravenous immunoglobulin therapy on serum levels of IgG1\u00a0and IgG4\u00a0antidesmoglein 1\u00a0and antidesmoglein 3\u00a0antibodies in pemphigus vulgaris","volume":"144","author":"Green","year":"2008","journal-title":"Arch Dermatol"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498210004239?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498210004239?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,8]],"date-time":"2018-12-08T02:27:23Z","timestamp":1544236043000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498210004239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":19,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S0755498210004239"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2009.04.016","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}